Literature DB >> 3489975

HLA-DR antigens in rheumatoid arthritis. A Swiss collaborative study; final report. Swiss Federal Commission for the Rheumatic Diseases, Subcommission for Research.

.   

Abstract

In two separate Swiss multicenter studies on HLA antigens in rheumatoid arthritis, we found an increase in HLA-DR1 and DR4 and a decrease in HLA-DR5 and DR7, when compared with normal controls. Both seropositivity and latex-titers were inversely related to the presence of DR5 and DR7. There was no relationship with the presence of DR4. No significant relationship was found between HLA antigens and particular features of rheumatoid arthritis such as extraarticular manifestations, prognosis, response to slow-acting antirheumatic drugs, side effects with slow-acting antirheumatic drugs.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3489975

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  36 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  HLA--Dw4 and rheumatoid arthritis.

Authors:  M Thomsen; N Morling; E Snorrason; A Svejgaard; S F Sørensen
Journal:  Tissue Antigens       Date:  1979-01

Review 3.  Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.

Authors:  J M Moll; I Haslock; I F Macrae; V Wright
Journal:  Medicine (Baltimore)       Date:  1974-09       Impact factor: 1.889

4.  An attempt to predict the response to gold therapy in rheumatoid arthritis.

Authors:  J D O'Duffy; W M O'Fallon; G G Hunder; F C McDuffie; S B Moore
Journal:  Arthritis Rheum       Date:  1984-11

5.  [Evaluation of 2 methods for detecting anti-DNA antibodies in collagen disease].

Authors:  M Fallet; A Celada; A Cruchaud
Journal:  Schweiz Med Wochenschr       Date:  1981-04-04

6.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis.

Authors:  B Schiff; Y Mizrachi; S Orgad; M Yaron; E Gazit
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

7.  HLA-DR antigens and disease patterns of rheumatoid arthritis.

Authors:  O Scherak; J S Smolen; W R Mayr
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

8.  The relationship between aurothioglucose- and D-penicillamine-induced proteinuria.

Authors:  F Speerstra; L B van de Putte; J J Rasker; P Reekers; J P Vandenbroucke
Journal:  Scand J Rheumatol       Date:  1984       Impact factor: 3.641

9.  D-Penicillamine induced toxicity in rheumatoid arthritis: the role of sulphoxidation status and HLA-DR3.

Authors:  P Emery; G S Panayi; G Huston; K I Welsh; S C Mitchell; R R Shah; J R Idle; R L Smith; R H Waring
Journal:  J Rheumatol       Date:  1984-10       Impact factor: 4.666

10.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis.

Authors:  P H Wooley; J Griffin; G S Panayi; J R Batchelor; K I Welsh; T J Gibson
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245
View more
  5 in total

Review 1.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

Review 2.  Polygenic susceptibility in rheumatoid arthritis.

Authors:  P Wordsworth; J Bell
Journal:  Ann Rheum Dis       Date:  1991-06       Impact factor: 19.103

3.  Only weak association between disease severity and HLA-DRB 1 genes in a Swiss population of rheumatoid arthritis patients.

Authors:  M Seitz; M Perler; W Pichler
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

4.  HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients.

Authors:  B Lang; I Melchers; A Urlacher; R F Tanzi-Fetta; S Kohlbrenner; M M Tongio; H H Peter
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

5.  Sjogren's syndrome in Israel: primary versus secondary disease.

Authors:  M Tishler; A Aharon; M Ehrenfeld; I Avni; E Bendet; S Bombardieri; M Yaron; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.